SONOVA HOLDING AG-REG (PHBN.DE) Stock Fundamental Analysis
FRA:PHBN - CH0012549785 - Common Stock
256 EUR
+7.4 (+2.98%)
Overall PHBN gets a fundamental rating of 7 out of 10. We evaluated PHBN against 58 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making PHBN a very profitable company, without any liquidiy or solvency issues. PHBN has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHBN was profitable.
In the past year PHBN had a positive cash flow from operations.
In the past 5 years PHBN has always been profitable.
Each year in the past 5 years PHBN had a positive operating cash flow.
1.2 Ratios
PHBN has a better Return On Assets (9.12%) than 86.21% of its industry peers.
The Return On Equity of PHBN (20.28%) is better than 86.21% of its industry peers.
With an excellent Return On Invested Capital value of 11.94%, PHBN belongs to the best of the industry, outperforming 89.66% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PHBN is above the industry average of 8.86%.
The last Return On Invested Capital (11.94%) for PHBN is above the 3 year average (11.68%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 20.28% | ||
| ROIC | 11.94% |
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
1.3 Margins
PHBN has a better Profit Margin (13.98%) than 82.76% of its industry peers.
In the last couple of years the Profit Margin of PHBN has declined.
Looking at the Operating Margin, with a value of 19.41%, PHBN belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
In the last couple of years the Operating Margin of PHBN has grown nicely.
PHBN has a Gross Margin of 72.43%. This is amongst the best in the industry. PHBN outperforms 84.48% of its industry peers.
PHBN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.41% | ||
| PM (TTM) | 13.98% | ||
| GM | 72.43% |
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PHBN is creating value.
Compared to 1 year ago, PHBN has about the same amount of shares outstanding.
Compared to 5 years ago, PHBN has less shares outstanding
PHBN has a better debt/assets ratio than last year.
2.2 Solvency
PHBN has an Altman-Z score of 4.58. This indicates that PHBN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.58, PHBN belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
PHBN has a debt to FCF ratio of 2.22. This is a good value and a sign of high solvency as PHBN would need 2.22 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.22, PHBN belongs to the top of the industry, outperforming 81.03% of the companies in the same industry.
A Debt/Equity ratio of 0.52 indicates that PHBN is somewhat dependend on debt financing.
PHBN's Debt to Equity ratio of 0.52 is on the low side compared to the rest of the industry. PHBN is outperformed by 62.07% of its industry peers.
Even though the debt/equity ratio score it not favorable for PHBN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.22 | ||
| Altman-Z | 4.58 |
ROIC/WACC2.59
WACC4.6%
2.3 Liquidity
A Current Ratio of 1.27 indicates that PHBN should not have too much problems paying its short term obligations.
PHBN has a Current ratio of 1.27. This is in the lower half of the industry: PHBN underperforms 67.24% of its industry peers.
PHBN has a Quick Ratio of 1.27. This is a bad value and indicates that PHBN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, PHBN is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
The current and quick ratio evaluation for PHBN is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for PHBN have decreased by -9.95% in the last year.
PHBN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.64% yearly.
PHBN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.58%.
PHBN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-9.95%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-6.88%
Revenue 1Y (TTM)6.58%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%8.45%
3.2 Future
PHBN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.14% yearly.
PHBN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.71% yearly.
EPS Next Y20.85%
EPS Next 2Y16.14%
EPS Next 3Y14.39%
EPS Next 5Y12.14%
Revenue Next Year4.3%
Revenue Next 2Y5.21%
Revenue Next 3Y5.19%
Revenue Next 5Y5.71%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
PHBN is valuated quite expensively with a Price/Earnings ratio of 26.56.
Based on the Price/Earnings ratio, PHBN is valued a bit cheaper than the industry average as 70.69% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.06. PHBN is around the same levels.
The Price/Forward Earnings ratio is 21.98, which indicates a rather expensive current valuation of PHBN.
PHBN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PHBN is cheaper than 63.79% of the companies in the same industry.
PHBN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.56 | ||
| Fwd PE | 21.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, PHBN is valued a bit cheaper than 65.52% of the companies in the same industry.
79.31% of the companies in the same industry are more expensive than PHBN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.85 | ||
| EV/EBITDA | 15.1 |
4.3 Compensation for Growth
PHBN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHBN may justify a higher PE ratio.
PHBN's earnings are expected to grow with 14.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.27
PEG (5Y)7.3
EPS Next 2Y16.14%
EPS Next 3Y14.39%
5. Dividend
5.1 Amount
PHBN has a Yearly Dividend Yield of 1.85%.
Compared to an average industry Dividend Yield of 2.16, PHBN pays a bit more dividend than its industry peers.
PHBN's Dividend Yield is slightly below the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
5.2 History
On average, the dividend of PHBN grows each year by 7.88%, which is quite nice.
Dividend Growth(5Y)7.88%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
47.40% of the earnings are spent on dividend by PHBN. This is a bit on the high side, but may be sustainable.
The dividend of PHBN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP47.4%
EPS Next 2Y16.14%
EPS Next 3Y14.39%
FRA:PHBN (9/5/2025, 7:00:00 PM)
256
+7.4 (+2.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners51.8%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap15.27B
Analysts52.59
Price Target287.3 (12.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.85% |
Yearly Dividend4.58
Dividend Growth(5Y)7.88%
DP47.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.18%
PT rev (3m)-4.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-7.08%
EPS NY rev (3m)-7.08%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-2.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.56 | ||
| Fwd PE | 21.98 | ||
| P/S | 3.71 | ||
| P/FCF | 21.85 | ||
| P/OCF | 18.06 | ||
| P/B | 5.38 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.1 |
EPS(TTM)9.64
EY3.77%
EPS(NY)11.65
Fwd EY4.55%
FCF(TTM)11.72
FCFY4.58%
OCF(TTM)14.18
OCFY5.54%
SpS69.03
BVpS47.59
TBVpS-5.72
PEG (NY)1.27
PEG (5Y)7.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.12% | ||
| ROE | 20.28% | ||
| ROCE | 16.95% | ||
| ROIC | 11.94% | ||
| ROICexc | 14.18% | ||
| ROICexgc | 71.32% | ||
| OM | 19.41% | ||
| PM (TTM) | 13.98% | ||
| GM | 72.43% | ||
| FCFM | 16.97% |
ROA(3y)10.39%
ROA(5y)10.52%
ROE(3y)24.63%
ROE(5y)24.39%
ROIC(3y)11.68%
ROIC(5y)11.31%
ROICexc(3y)13.28%
ROICexc(5y)13.73%
ROICexgc(3y)57.29%
ROICexgc(5y)71.13%
ROCE(3y)16.59%
ROCE(5y)16.07%
ROICexcg growth 3Y-12.61%
ROICexcg growth 5Y7.75%
ROICexc growth 3Y-3.74%
ROICexc growth 5Y4.49%
OM growth 3Y-5.82%
OM growth 5Y2.12%
PM growth 3Y-10.17%
PM growth 5Y-3.33%
GM growth 3Y-0.36%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 2.22 | ||
| Debt/EBITDA | 1.39 | ||
| Cap/Depr | 55.37% | ||
| Cap/Sales | 3.56% | ||
| Interest Coverage | 28.96 | ||
| Cash Conversion | 79.48% | ||
| Profit Quality | 121.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 4.58 |
F-Score7
WACC4.6%
ROIC/WACC2.59
Cap/Depr(3y)57.33%
Cap/Depr(5y)52.51%
Cap/Sales(3y)3.74%
Cap/Sales(5y)3.57%
Profit Quality(3y)107.52%
Profit Quality(5y)113.47%
High Growth Momentum
Growth
EPS 1Y (TTM)-9.95%
EPS 3Y-4.38%
EPS 5Y3.64%
EPS Q2Q%-6.88%
EPS Next Y20.85%
EPS Next 2Y16.14%
EPS Next 3Y14.39%
EPS Next 5Y12.14%
Revenue 1Y (TTM)6.58%
Revenue growth 3Y4.74%
Revenue growth 5Y5.79%
Sales Q2Q%8.45%
Revenue Next Year4.3%
Revenue Next 2Y5.21%
Revenue Next 3Y5.19%
Revenue Next 5Y5.71%
EBIT growth 1Y6.05%
EBIT growth 3Y-1.35%
EBIT growth 5Y8.03%
EBIT Next Year41.54%
EBIT Next 3Y17.46%
EBIT Next 5Y12.85%
FCF growth 1Y5.03%
FCF growth 3Y-7.7%
FCF growth 5Y-1.69%
OCF growth 1Y5.36%
OCF growth 3Y-5.52%
OCF growth 5Y-1.21%